Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Audited Consolidated ....
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Senores Pharmaceuticals Limited has informed exchanges about a Board meeting scheduled for May 14, 2026. The meeting will consider and approve the audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026. The company has also reminded stakeholders that the trading window for insiders remains closed until 48 hours after the results are approved and submitted to exchanges. This is a routine regulatory intimation under SEBI LODR regulations and does not contain any financial figures or performance data.
This is a standard pre-results announcement notice with no material information for investors until the actual results are disclosed. Shareholders should expect the audited financial results to be released after the May 14, 2026 board meeting.